| Mr Basilio Espino Lopez, PT | |
|
21 Ryder Pl Ste 1000, East Rockaway, NY 11518-1200 | |
| (516) 665-2023 | |
| (888) 773-1644 |
| Full Name | Mr Basilio Espino Lopez |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 25 Years |
| Location | 21 Ryder Pl Ste 1000, East Rockaway, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659515823 | NPI | - | NPPES |
| 03487501 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 027734-1 (New York) | Primary |
| Provider Name | Bel Rehabilitation Pt Pc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1184963308 PECOS PAC ID: 3375760929 Enrollment ID: O20141114001287 |
News Archive
Researchers at the University of California, Berkeley, have for the first time captured elusive nanoscale movements of ribosomes at work, shedding light on how these cellular factories take in genetic instructions and amino acids to churn out proteins.
People who have received a donor organ need lifelong immunosuppressant drugs to keep their immune system from attacking the foreign tissue. However, with a suppressed immune system, many infectious agents turn into a threat. Infections such as with human cytomegalovirus and a certain type of human polyomavirus frequently cause complications in transplant recipients.
Generex Biotechnology Corporation today announced its receipt of a decision by the NASDAQ Listing Qualifications Panel, which granted the Company's request for continued listing of the Company's common stock on The NASDAQ Stock Market on an interim basis, subject to certain conditions subsequent which are described in the Form 8-K Current Report filed by the Company with the Securities and Exchange Commission on EDGAR earlier today.
A team of investigators at The Cancer Institute of New Jersey (CINJ); Rutgers, The State University of New Jersey; and Princeton University, have determined that cancer cells are "addicted" to a self-preservation process known as autophagy. They also showed that the inhibition of that process could prove to be a valuable treatment approach for aggressive cancers. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
A drug that targets the body's immune cells may be effective in treating malignant brain tumors, according to a new study led by researchers from Duke's Preston Robert Tisch Brain Tumor Center.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Basilio Espino Lopez, PT 21 Ryder Pl Ste 1000, East Rockaway, NY 11518-1200 Ph: (516) 665-2023 | Mr Basilio Espino Lopez, PT 21 Ryder Pl Ste 1000, East Rockaway, NY 11518-1200 Ph: (516) 665-2023 |
News Archive
Researchers at the University of California, Berkeley, have for the first time captured elusive nanoscale movements of ribosomes at work, shedding light on how these cellular factories take in genetic instructions and amino acids to churn out proteins.
People who have received a donor organ need lifelong immunosuppressant drugs to keep their immune system from attacking the foreign tissue. However, with a suppressed immune system, many infectious agents turn into a threat. Infections such as with human cytomegalovirus and a certain type of human polyomavirus frequently cause complications in transplant recipients.
Generex Biotechnology Corporation today announced its receipt of a decision by the NASDAQ Listing Qualifications Panel, which granted the Company's request for continued listing of the Company's common stock on The NASDAQ Stock Market on an interim basis, subject to certain conditions subsequent which are described in the Form 8-K Current Report filed by the Company with the Securities and Exchange Commission on EDGAR earlier today.
A team of investigators at The Cancer Institute of New Jersey (CINJ); Rutgers, The State University of New Jersey; and Princeton University, have determined that cancer cells are "addicted" to a self-preservation process known as autophagy. They also showed that the inhibition of that process could prove to be a valuable treatment approach for aggressive cancers. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
A drug that targets the body's immune cells may be effective in treating malignant brain tumors, according to a new study led by researchers from Duke's Preston Robert Tisch Brain Tumor Center.
› Verified 7 days ago
Caring Rehab Pt Pllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 131 Marina Pointe Dr, East Rockaway, NY 11518 Phone: 929-328-6432 | |
Kathleen Acuti, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 72 Dart St, East Rockaway, NY 11518 Phone: 914-309-3497 | |
Yogeshkumar Makvana, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 131 Marina Pointe Dr, East Rockaway, NY 11518 Phone: 929-328-6432 |